These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 32412431)
1. Antitumor effect of a pyrazolone-based-complex [Cu(PMPP-SAL)(EtOH)] against murine melanoma B16 cell in vitro and in vivo. Abula A; Zhao J; Xu G; Li Y; Sun S Acta Pharm; 2020 Dec; 70(4):561-575. PubMed ID: 32412431 [TBL] [Abstract][Full Text] [Related]
2. Apoptotic effect of novel pyrazolone-based derivative [Cu(PMPP-SAL)(EtOH)] on HeLa cells and its mechanism. Reheman D; Zhao J; Guan S; Xu GC; Li YJ; Sun SR Sci Rep; 2020 Oct; 10(1):18235. PubMed ID: 33106514 [TBL] [Abstract][Full Text] [Related]
3. A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway. Zhao J; Zhang L; Li J; Wu T; Wang M; Xu G; Zhang F; Liu L; Yang J; Sun S Chem Biol Interact; 2015 Apr; 231():1-9. PubMed ID: 25684395 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic activity of the penicillin derivative TAP7f in melanoma. Barrionuevo E; Cornier PG; Delpiccolo CML; Mata EG; Roguin LP; Blank VC J Mol Med (Berl); 2023 Mar; 101(3):249-263. PubMed ID: 36688961 [TBL] [Abstract][Full Text] [Related]
5. The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell growth in vitro and in vivo. Liu KS; Ding WC; Wang SX; Liu Z; Xing GW; Wang Y; Wang YF Oncol Rep; 2012 Jun; 27(6):1904-10. PubMed ID: 22447251 [TBL] [Abstract][Full Text] [Related]
7. YoshixolTR inhibits B16 melanoma cell growth in vivo and induces apoptosis-like (quantum thermodynamic) cell death. Koyama S; Tanaka S; Haniu H; Yamaguchi Y; Motoyoshiya J Gen Pharmacol; 1999 Aug; 33(2):161-72. PubMed ID: 10461854 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993 [TBL] [Abstract][Full Text] [Related]
9. Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis. Li T; Liu X; Shen Q; Yang W; Huo Z; Liu Q; Jiao H; Chen J Oncotarget; 2016 May; 7(18):26580-92. PubMed ID: 27058891 [TBL] [Abstract][Full Text] [Related]
10. Antitumoral synergism between a copper(II) complex and cisplatin improves in vitro and in vivo anticancer activity against melanoma, lung and breast cancer cells. Mariani D; Ghasemishahrestani Z; Freitas W; Pezzuto P; Costa-da-Silva AC; Tanuri A; Kanashiro MM; Fernandes C; Horn A; Pereira MD Biochim Biophys Acta Gen Subj; 2021 Oct; 1865(10):129963. PubMed ID: 34246719 [TBL] [Abstract][Full Text] [Related]
11. A New Synthetic Spiroketal: Studies on Antitumor Activity on Murine Melanoma Model In Vivo and Mechanism of Action In Vitro. Fuggetta MP; Spanu P; Ulgheri F; Deligia F; Carta P; Mannu A; Trotta V; De Cicco R; Barra A; Zona E; Morelli F Anticancer Agents Med Chem; 2019; 19(4):567-578. PubMed ID: 30706794 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma. Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548 [TBL] [Abstract][Full Text] [Related]
13. Ilexgenin A induces B16-F10 melanoma cell G1/S arrest in vitro and reduces tumor growth in vivo. Yang H; Liu C; Zhang YQ; Ge LT; Chen J; Jia XQ; Gu RX; Sun Y; Sun WD Int Immunopharmacol; 2015 Feb; 24(2):423-431. PubMed ID: 25596038 [TBL] [Abstract][Full Text] [Related]
14. Phyto-sesquiterpene lactone deoxyelephantopin and cisplatin synergistically suppress lung metastasis of B16 melanoma in mice with reduced nephrotoxicity. Chao WW; Cheng YW; Chen YR; Lee SH; Chiou CY; Shyur LF Phytomedicine; 2019 Mar; 56():194-206. PubMed ID: 30668340 [TBL] [Abstract][Full Text] [Related]
15. Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling. Gao J; Hu H; Wang X Cancer Chemother Pharmacol; 2019 Jun; 83(6):1007-1015. PubMed ID: 30887179 [TBL] [Abstract][Full Text] [Related]
16. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041 [TBL] [Abstract][Full Text] [Related]
17. Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase. Ferreira AK; Meneguelo R; Marques FL; Radin A; Filho OM; Neto SC; Chierice GO; Maria DA Biomed Pharmacother; 2012 Oct; 66(7):541-8. PubMed ID: 22902646 [TBL] [Abstract][Full Text] [Related]
18. Melanoma tumor inhibition by tetrachlorido(O,O'-dibutyl-ethylenediamine-N,N'-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigations. Maksimović-Ivanić D; Mijatović S; Mirkov I; Stošić-Grujičić S; Miljković D; Sabo TJ; Trajković V; Kaluđerović GN Metallomics; 2012 Nov; 4(11):1155-9. PubMed ID: 23014886 [TBL] [Abstract][Full Text] [Related]
19. Diphenhydramine induces melanoma cell apoptosis by suppressing STAT3/MCL-1 survival signaling and retards B16-F10 melanoma growth in vivo. Or CR; Su HL; Lee WC; Yang SY; Ho C; Chang CC Oncol Rep; 2016 Dec; 36(6):3465-3471. PubMed ID: 27779705 [TBL] [Abstract][Full Text] [Related]
20. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]